Skip to main content

Tag: Accelerator

April 27th, 2016

Advancing ingenuity

Five research projects with commercial potential receive sustaining funding through Harvard’s Physical Sciences & Engineering Accelerator.

Microfluidics 400sq opt

August 19th, 2015

Bridging the biomedical development gap

Twelve advanced research projects aimed at developing new therapies and diagnostics receive support in 2015-16 from Harvard’s Blavatnik Biomedical Accelerator.

Blavatnik 400sq

March 4th, 2015

Harvard startup launches with $22M Series A financing to develop novel macrolide antibiotics

NEWTON, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis Venture Fund, Gurnet Point Capital, Roche Ventures, and SROne. The financing follows a worldwide license agreement between Harvard's Office of Technology Development and the company, providing exclusive rights to the technology.

Page 4 of 5